|

VS-6766/avutometinib Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1/2: 1

Top Sponsors

  • University of Chicago1

Indications

  • Advanced Colorectal Adenocarcinoma1
  • Advanced Colorectal Carcinoma1
  • Colorectal Adenocarcinoma1
  • Colorectal Cancer Metastatic1
  • Colorectal Cancer1

Chicago, Illinois1 trial

A Study of VS-6766 and Cetuximab in Patients With Advanced Colorectal Cancer

University of Chicago Medical Center

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.